FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Takuji Okusaka

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Co-author Network

Publications

TOP 3
Hideki Ueno; Taketo Yamaguchi; Kenji Yamao; Hiroaki Yanagimoto; Hideo Baba; Narikazu Boku; Jen-Shi Chen; Ann-Lii Cheng; Shinichi Egawa; Akira Fukutomi; Akihiro Funakoshi; Junji Furuse; Takashi Hatori; Masafumi Ikeda; Tatsuya Ioka; Masayuki Kitano; Kazuhiro Mizumoto; Yasuo Ohashi; Shinichi Ohkawa; Takuji Okusaka; Atsushi Sato; Tomotaka Shimamura; Masayuki Sho; Kazuya Sugimori; Masao Tanaka
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study.
Eiichiro Suzuki; Hiroaki Yanagimoto; Narikazu Boku; Masafumi Ikeda; Tatsuya Nagakawa; Shoji Nakamori; Shinichi Ohkawa; Takuji Okusaka; Tosiya Sato; Junji Furuse
A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer.
Masafumi Ikeda; Yoshitaka Inaba; Jae Kyu Kim; Se Hwan Kwon; Takuji Okusaka; Sang Joon Park; Yoshito Takeuchi; Seiichiro Yamamoto; Hiroshi Anai; Yasuaki Arai; Takeshi Aramaki
Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Takuji Okusaka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hideki Ueno; Taketo Yamaguchi; Kenji Yamao; Hiroaki Yanagimoto; Hideo Baba; Narikazu Boku; Jen-Shi Chen; Ann-Lii Cheng; Shinichi Egawa; Akira Fukutomi; Akihiro Funakoshi; Junji Furuse; Takashi Hatori; Masafumi Ikeda; Tatsuya Ioka; Masayuki Kitano; Kazuhiro Mizumoto; Yasuo Ohashi; Shinichi Ohkawa; Takuji Okusaka; Atsushi Sato; Tomotaka Shimamura; Masayuki Sho; Kazuya Sugimori; Masao Tanaka
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(13):1640-8.
2013: Eiichiro Suzuki; Hiroaki Yanagimoto; Narikazu Boku; Masafumi Ikeda; Tatsuya Nagakawa; Shoji Nakamori; Shinichi Ohkawa; Takuji Okusaka; Tosiya Sato; Junji Furuse
A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer.
Cancer chemotherapy and pharmacology 2013;71(5):1141-6.
2013: Masafumi Ikeda; Yoshitaka Inaba; Jae Kyu Kim; Se Hwan Kwon; Takuji Okusaka; Sang Joon Park; Yoshito Takeuchi; Seiichiro Yamamoto; Hiroshi Anai; Yasuaki Arai; Takeshi Aramaki
Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
Journal of vascular and interventional radiology : JVIR 2013;24(4):490-500.
2013: Shunsuke Kondo; Chigusa Morizane; Hidenori Ojima; Kazuaki Shimada; Kenji Tamura; Hitoshi Tsuda; Hideki Ueno; Jun Hashimoto; Masafumi Ikeda; Yae Kanai; Takuji Okusaka
Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma.
International journal of clinical oncology 2013;18(2):207-13.
2013: Junji Furuse; Hiroshi Ishii; Takuji Okusaka
The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.
Japanese journal of clinical oncology 2013;43(1):2-7.
2013: Masafumi Ikeda; Tatsuya Ioka; Hiroshi Ishii; Yoshinori Ito; Hiroyuki Miyakawa; Michitaka Nagase; Keiko Sato; Tosiya Sato; Kenji Yamao; Naohiro Yonemoto; Junji Furuse; Takuji Okusaka
A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2013;85(1):163-9.
2012: Tetsuhide Ito; Akio Kasuga; Chigusa Morizane; Kohei Nakachi; Takuji Okusaka; Takeshi Tajima; Yoshie Fujita; Hisato Igarashi; Masafumi Ikeda; Junji Furuse
Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial.
Japanese journal of clinical oncology 2012;42(10):903-11.
2012: Shinichi Egawa; Takashi Hatori; Hiroyuki Maguchi; Akimasa Nakao; Hiroaki Ohigashi; Takuji Okusaka; Hiroki Toma; Akio Yanagisawa; Masao Tanaka
Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society.
Pancreas 2012;41(7):985-92.
2012: Takuji Okusaka; Hidetugu Saito; Isao Sakaida; Michio Sata; Toshihito Seki; Yasukazu Shioyama; Keiko Shiratori; Katsuaki Tanaka; Takuya Tsutsumi; Masaharu Yoshikawa; Kazuaki Chayama; Naoaki Hayashi; Masao Honda; Hiroshi Ishii; Hiroshi Kasugai; Masatoshi Kudo; Hiromitsu Kumada; Yukio Kusumoto; Kiwamu Okita; Kenji Sakata
A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma.
Investigational new drugs 2012;30(5):2015-25.
2012: Satoshi Shiba; Hideki Ueno; Masafumi Ikeda; Shunsuke Kondo; Chigusa Morizane; Takuji Okusaka
Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma.
Case reports in oncology 2012;5(3):515-9.
2012: Tomoko Katsui Taniyama; Hideki Ueno; Kazuaki Shimada; Shinichiro Takahashi; Minoru Esaki; Masafumi Ikeda; Taira Kinoshita; Shunsuke Kondo; Masaru Konishi; Tomoo Kosuge; Shuichi Mitsunaga; Chigusa Morizane; Kohei Nakachi; Satoshi Nara; Takuji Okusaka
Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapy.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2012;12(5):428-33.
2012: Hidenori Kido; Shunsuke Kondo; Chigusa Morizane; Tetsutaro Tamura; Hideki Ueno; Atsushi Hagihara; Takuji Okusaka
Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer.
Japanese journal of clinical oncology 2012;42(9):845-50.
2012: Masafumi Ikeda; Akiko Kuwahara; Shuichi Mitsunaga; Izumi Ohno; Hiroyuki Okuyama; Satoshi Shimizu; Hideaki Takahashi; Takuji Okusaka
[Current status and future perspective of sorafenib for advanced hepatocellular carcinoma].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2012;109(8):1346-54.
2012: Takuji Okusaka; Yoriko Takezako; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane
Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma.
Cancer science 2012;103(8):1524-30.
2012: Atsushi Naganuma; Hideki Ueno; Atsushi Hagihara; Jun Itami; Yuriko Ito; Shunsuke Kondo; Hiroshi Mayahara; Chigusa Morizane; Takuji Okusaka
Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases.
Japanese journal of clinical oncology 2012;42(7):640-5.
2012: Takuji Okusaka; Tosiya Sato; Makoto Ueno; Yuji Heike
Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial).
Journal of hepato-biliary-pancreatic sciences 2012;19(4):314-8.
2012: Akira Fukutomi; Junji Furuse; Minori Koshiji; Masaru Miyazaki; Takuji Okusaka; Masanori Taketsuna; Yuji Nimura
Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study.
HPB : the official journal of the International Hepato Pancreato Biliary Association 2012;14(4):221-7.
2012: Chigusa Morizane; Kohei Nakachi; Takuji Okusaka; Ohkawa Shinichi; Eiichiro Suzuki; Hideki Ueno; Makoto Ueno; Junji Furuse; Masafumi Ikeda; Yasushi Kojima; Shunsuke Kondo; Shuichi Mitsunaga; Tomohiro Yamaguchi
Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients.
Cancer chemotherapy and pharmacology 2012;69(4):957-64.
2012: Hideki Ueno; Takuji Okusaka
[Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(3):357-63.
2012: Noriaki Morofuji; Masato Nagino; Satoshi Nara; Hidenori Ojima; Takuji Okusaka; Hiroaki Onaya; Yoshihiro Sakamoto; Kazuaki Shimada; Masahiko Ushigome; Daisuke Asahina; Minoru Esaki; Nobuyoshi Hiraoka; Tomoo Kosuge; Tadashi Kondo
Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma.
Journal of proteomics 2012;75(5):1577-89.
2012: Hideki Ueno; Takuji Okusaka
[Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma; 4. Progress of non-surgical treatment for pancreatic cancer].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2012;101(1):29-36.
2012: Hiroshi Mayahara; Chigusa Morizane; Madoka Morota; Naoya Murakami; Takuji Okusaka; Minako Sumi; Hideki Ueno; Yoshinori Ito; Shunsuke Kondo; Jun Itami
Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis.
BMC cancer 2012;12():609.
2012: Kazufumi Honda; Tatsuya Ioka; Tomoo Kosuge; Hideya Kuwabara; Hideo Nagai; Shoji Nakamori; Takuji Okusaka; Norihito Ota; Yoshihiko Otsuka; Tomohiro Sakuma; Naohiro Sata; Masashi Shimahara; Takeshi Shimahara; Miki Shitashige; Akihiko Tsuchida; Markus W Büchler; Klaus Felix; Yohichi Yasunami; Tesshi Yamada
Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation.
PloS one 2012;7(10):e46908.
2012: Shunsuke Kondo; Chigusa Morizane; Takuji Okusaka; Jun Hashimoto; Fumiaki Koizumi; Hideki Ueno; Kenji Tamura
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy.
BMC cancer 2012;12():268.
2012: T Terashima; Hitoshi Tsuda; H Ueno; Yasuhiro Shimada; Tomohide Tamura; N Hiraoka; Masafumi Ikeda; S Kaneko; S Kondo; R Kushima; C Morizane; Takuji Okusaka
Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma.
Neuroendocrinology 2012;96(4):324-32.
2011: Takuji Okusaka
[Progression of chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2011;38(10):1613-8.
2011: Junichi Matsubara; Hideo Nagai; Shoji Nakamori; Takuji Okusaka; Masaya Ono; Tomohiro Sakuma; Naohiro Sata; Shigeki Sekine; Masashi Shimahara; Yoshinori Tanaka; Akihiko Tsuchida; Tsutomu Chiba; Kazufumi Honda; Tatsuya Ioka; Giman Jung; Michimoto Kobayashi; Tomoo Kosuge; Yohichi Yasunami; Tesshi Yamada
Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(10):2195-203.
2011: Junji Furuse; Minori Koshiji; Takuji Okusaka; Masanori Taketsuna; John Bridgewater; Harpreet Wasan; Juan Valle
Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer.
Critical reviews in oncology/hematology 2011;80(1):31-9.
2011: Masatoshi Kudo; Hiromitsu Kumada; Osamu Matsui; Gerold Meinhardt; Kohei Nakachi; Toshio Ohya; Nobuyuki Chida; Junji Furuse; Norio Hayashi; Takeshi Hori; Kazuho Imanaka; Shuichi Kaneko; Takuji Okusaka; Dong Jin Suh; Won-Young Tak; Tadatoshi Takayama; Katsuaki Tanaka; Hirohito Tsubouchi; Michihiko Wada; Iku Yamaguchi; Jung-Hwan Yoon; Kiwamu Okita
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.
European journal of cancer (Oxford, England : 1990) 2011;47(14):2117-27.
2011: Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane
Phase I and pharmacokinetic clinical trial of oral administration of the acyclic retinoid NIK-333.
Hepatology research : the official journal of the Japan Society of Hepatology 2011;41(6):542-52.
2011: Satoru Iwasa; Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Kohei Nakachi; Shuichi Mitsunaga; Shunsuke Kondo; Atsushi Hagihara; Satoshi Shimizu; Mitsuo Satake; Yasuaki Arai
Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
Japanese journal of clinical oncology 2011;41(6):770-5.
2011: Yasushi Totoki; Kenji Tatsuno; Shogo Yamamoto; Yasuhito Arai; Fumie Hosoda; Shumpei Ishikawa; Shuichi Tsutsumi; Kohtaro Sonoda; Hirohiko Totsuka; Takuya Shirakihara; Hiromi Sakamoto; Linghua Wang; Hidenori Ojima; Kazuaki Shimada; Tomoo Kosuge; Takuji Okusaka; Kazuto Kato; Jun Kusuda; Teruhiko Yoshida; Hiroyuki Aburatani; Tatsuhiro Shibata
High-resolution characterization of a hepatocellular carcinoma genome.
Nature genetics 2011;43(5):464-9.
2011: Chigusa Morizane; Takuji Okusaka; Satoshi Morita; Katsuaki Tanaka; Hideki Ueno; Shunsuke Kondo; Masafumi Ikeda; Kohei Nakachi; Shuichi Mitsunaga
Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma.
Pancreas 2011;40(3):415-21.
2011: Takuji Okusaka; Hideki Ueno; Shunsuke Kondo; Chigusa Morizane; Tomohiro Yamaguchi
[Medical treatment of pancreatic neuroendocrine tumor].
Nihon rinsho. Japanese journal of clinical medicine 2011;69 Suppl 2():617-20.
2011: Hedy L Kindler; Tatsuya Ioka; Dirk J Richel; Jaafar Bennouna; Richard Létourneau; Takuji Okusaka; Akihiro Funakoshi; Junji Furuse; Young Suk Park; Shinichi Ohkawa; Gregory M Springett; Harpreet S Wasan; Peter C Trask; Paul Bycott; Alejandro D Ricart; Sinil Kim; Eric Van Cutsem
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.
The lancet oncology 2011;12(3):256-62.
2011: Yusuke Murakoshi; Kazufumi Honda; Shizuka Sasazuki; Masaya Ono; Ayako Negishi; Junichi Matsubara; Tomohiro Sakuma; Hideya Kuwabara; Shoji Nakamori; Naohiro Sata; Hideo Nagai; Tatsuya Ioka; Takuji Okusaka; Tomoo Kosuge; Masashi Shimahara; Yohichi Yasunami; Yoshinori Ino; Akihiko Tsuchida; Tatsuya Aoki; Shoichiro Tsugane; Tesshi Yamada
Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray.
Cancer science 2011;102(3):630-8.
2011: Eiichiro Suzuki; Junji Furuse; Masafumi Ikeda; Hiroshi Ishii; Takuji Okusaka; Kohei Nakachi; Shuichi Mitsunaga; Hideki Ueno; Chigusa Morizane
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Japanese journal of clinical oncology 2011;41(3):328-33.
2011: James C Yao; Manisha H Shah; Tetsuhide Ito; Catherine Lombard Bohas; Edward M Wolin; Eric Van Cutsem; Timothy J Hobday; Takuji Okusaka; Jaume Capdevila; Elisabeth G E de Vries; Paola Tomassetti; Marianne E Pavel; Sakina Hoosen; Tomas Haas; Jeremie Lincy; David Lebwohl; Kjell Öberg
Everolimus for advanced pancreatic neuroendocrine tumors.
The New England journal of medicine 2011;364(6):514-23.
2011: Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shinichi Ohkawa; Narikazu Boku; Yoshito Komatsu; Shoji Nakamori; Haruo Iguchi; Tetsuhide Ito; Kazuhiko Nakagawa; Kohei Nakachi
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer.
Cancer science 2011;102(2):425-31.
2011: Fumihiko Kanai; Haruhiko Yoshida; Ryosuke Tateishi; Shinpei Sato; Takao Kawabe; Shuntaro Obi; Yuji Kondo; Makoto Taniguchi; Kazumi Tagawa; Masafumi Ikeda; Chigusa Morizane; Takuji Okusaka; Hitoshi Arioka; Shuichiro Shiina; Masao Omata
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 2011;67(2):315-24.
2011: Miho Kaida; Yuriko Morita-Hoshi; Atsuko Soeda; Takako Wakeda; Yuni Yamaki; Yasushi Kojima; Hideki Ueno; Shunsuke Kondo; Chigusa Morizane; Masafumi Ikeda; Takuji Okusaka; Yoichi Takaue; Yuji Heike
Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2011;34(1):92-9.
2011: Junichi Matsubara; Kazufumi Honda; Masaya Ono; Yoshinori Tanaka; Michimoto Kobayashi; Giman Jung; Koji Yanagisawa; Tomohiro Sakuma; Shoji Nakamori; Naohiro Sata; Hideo Nagai; Tatsuya Ioka; Takuji Okusaka; Tomoo Kosuge; Akihiko Tsuchida; Masashi Shimahara; Yohichi Yasunami; Tsutomu Chiba; Setsuo Hirohashi; Tesshi Yamada
Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(1):160-71.
2010: Junji Furuse; Takuji Okusaka; Shuichi Kaneko; Masatoshi Kudo; Kohei Nakachi; Hideki Ueno; Tatsuya Yamashita; Kazuomi Ueshima
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma.
Cancer science 2010;101(12):2606-11.
2010: Atsuko Soeda; Yuriko Morita-Hoshi; Miho Kaida; Takako Wakeda; Yuni Yamaki; Yasushi Kojima; Hideki Ueno; Shunsuke Kondo; Chigusa Morizane; Masafumi Ikeda; Takuji Okusaka; Yuji Heike
Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites.
Japanese journal of clinical oncology 2010;40(12):1184-8.
2010: Atsuo Takashima; Chigusa Morizane; Hiroshi Ishii; Kenichi Nakamura; Haruhiko Fukuda; Takuji Okusaka; Junji Furuse
Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805).
Japanese journal of clinical oncology 2010;40(12):1189-91.
2010: Keiko Sato; Tosiya Sato; Junji Furuse; Hiroshi Kasugai; Masaru Konishi; Tomoo Kosuge; Akiko Saito; Yo Sasaki; Ken Takasaki; Takuji Okusaka
A conundrum for randomized controlled trials: experience from a small hepatocellular carcinoma trial.
Japanese journal of clinical oncology 2010;40(10):949-53.
2010: Takuji Okusaka; Kohei Nakachi; A Fukutomi; N Mizuno; Shinichi Ohkawa; Akihiro Funakoshi; Masato Nagino; S Kondo; S Nagaoka; J Funai; M Koshiji; Y Nambu; Junji Furuse; M Miyazaki; Y Nimura
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.
British journal of cancer 2010;103(4):469-74.
2010: Emiko Sugiyama; Nahoko Kaniwa; Su-Ryang Kim; Ryuichi Hasegawa; Yoshiro Saito; Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Chigusa Morizane; Shunsuke Kondo; Noboru Yamamoto; Tomohide Tamura; Junji Furuse; Hiroshi Ishii; Teruhiko Yoshida; Nagahiro Saijo; Jun-Ichi Sawada
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.
Clinical pharmacokinetics 2010;49(8):549-58.
2010: Shunsuke Kondo; Hideki Ueno; Chigusa Morizane; Takuji Okusaka
[Hepatocellular carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 2010;37(7):1219-23.
2010: Hiroshi Ishii; Junji Furuse; Narikazu Boku; Takuji Okusaka; Masafumi Ikeda; Shinichi Ohkawa; Akira Fukutomi; Yasuo Hamamoto; Kenichi Nakamura; Haruhiko Fukuda
Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.
Japanese journal of clinical oncology 2010;40(6):573-9.
2010: Hidenori Ojima; Daitaro Yoshikawa; Yoshihiro Ino; Hiroko Shimizu; Masashi Miyamoto; Akiko Kokubu; Nobuyoshi Hiraoka; Noriaki Morofuji; Tadashi Kondo; Hiroaki Onaya; Takuji Okusaka; Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Satoshi Nara; Tomoo Kosuge; Setsuo Hirohashi; Yae Kanai; Tatsuhiro Shibata
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.
Cancer science 2010;101(4):882-8.
2010: Junichi Matsubara; Masaya Ono; Kazufumi Honda; Ayako Negishi; Hideki Ueno; Takuji Okusaka; Junji Furuse; Koh Furuta; Emiko Sugiyama; Yoshiro Saito; Nahoko Kaniwa; Junichi Sawada; Ayako Shoji; Tomohiro Sakuma; Tsutomu Chiba; Nagahiro Saijo; Setsuo Hirohashi; Tesshi Yamada
Survival prediction for pancreatic cancer patients receiving gemcitabine treatment.
Molecular & cellular proteomics : MCP 2010;9(4):695-704.
2010: Satoru Iwasa; Chigusa Morizane; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Shunsuke Kondo; Tsutomu Tanaka; Kohei Nakachi; Shuichi Mitsunaga; Yasushi Kojima; Atsushi Hagihara; Nobuyoshi Hiraoka
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
Japanese journal of clinical oncology 2010;40(4):313-8.
2010: Masafumi Ikeda; Kohei Nakachi; Shuichi Mitsunaga; Hideki Ueno; Chigusa Morizane; Shunsuke Kondo; Takuji Okusaka
[Chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2010;37(3):408-12.
2010: Kenji Ikeda; Takuji Okusaka; Masafumi Ikeda; Manabu Morimoto
[Transcatheter arterial chemoembolization with a lipophilic platinum complex SM-11355(miriplatin hydrate)--safety and efficacy in combination with embolizing agents].
Gan to kagaku ryoho. Cancer & chemotherapy 2010;37(2):271-5.
2010: Eiichiro Suzuki; Junji Furuse; Masafumi Ikeda; Takuji Okusaka; Kohei Nakachi; Shuichi Mitsunaga; Hideki Ueno; Chigusa Morizane; Shunsuke Kondo; Satoshi Shimizu; Yasushi Kojima; Atsushi Hagihara
Treatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 cases.
Oncology 2010;79(1-2):39-45.
2010: Siew-Kee Low; Aya Kuchiba; Hitoshi Zembutsu; Akira Saito; Atsushi Takahashi; Michiaki Kubo; Yataro Daigo; Naoyuki Kamatani; Suenori Chiku; Hirohiko Totsuka; Sumiko Ohnami; Hiroshi Hirose; K Shimada; Takuji Okusaka; Teruhiko Yoshida; Yusuke Nakamura; Hiromi Sakamoto
Genome-wide association study of pancreatic cancer in Japanese population.
PloS one 2010;5(7):e11824.
2009: Takuji Okusaka; Hiroshi Kasugai; yasukazu shioyama; Katsuaki Tanaka; Masatoshi Kudo; Hiromitsu Saisho; Yukio Osaki; Michio Sata; Shigetoshi Fujiyama; Takashi Kumada; Keiko Sato; Seiichiro Yamamoto; Shiro Hinotsu; Tosiya Sato
Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
Journal of hepatology 2009;51(6):1030-6.
2009: Atsuko Soeda; Yuriko Morita-Hoshi; Hiroaki Makiyama; Chigusa Morizane; Hideki Ueno; Masafumi Ikeda; Takuji Okusaka; Shizuka Yamagata; Noriko Takahashi; Ichinosuke Hyodo; Yoichi Takaue; Yuji Heike
Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer.
Japanese journal of clinical oncology 2009;39(12):797-806.
2009: Junji Furuse; Takuji Okusaka; Shinichi Ohkawa; Michitaka Nagase; Akihiro Funakoshi; Narikazu Boku; Kenji Yamao; Taketo Yamaguchi; Toshiya Sato
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Cancer chemotherapy and pharmacology 2009;65(1):113-20.
2009: Yoshitaka Seki; Takuji Okusaka; Masafumi Ikeda; Chigusa Morizane; Hideki Ueno
Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.
Japanese journal of clinical oncology 2009;39(11):751-5.
2009: Masaya Ono; Junichi Matsubara; Kazufumi Honda; Tomohiro Sakuma; Tomoyo Hashiguchi; Hiroshi Nose; Shoji Nakamori; Takuji Okusaka; Tomoo Kosuge; Naohiro Sata; Hideo Nagai; Tatsuya Ioka; Sachiko Tanaka; Akihiko Tsuchida; Tatsuya Aoki; Masashi Shimahara; Yohichi Yasunami; Takao Itoi; Fuminori Moriyasu; Ayako Negishi; Hideya Kuwabara; Ayako Shoji; Setsuo Hirohashi; Tesshi Yamada
Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics.
The Journal of biological chemistry 2009;284(42):29041-9.
2009: Junichi Matsubara; Masaya Ono; Ayako Negishi; Hideki Ueno; Takuji Okusaka; Junji Furuse; Koh Furuta; Emiko Sugiyama; Yoshiro Saito; Nahoko Kaniwa; Junichi Sawada; Kazufumi Honda; Tomohiro Sakuma; Tsutomu Chiba; Nagahiro Saijo; Setsuo Hirohashi; Tesshi Yamada
Identification of a predictive biomarker for hematologic toxicities of gemcitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2261-8.
2009: Hideki Ueno; Nahoko Kaniwa; Takuji Okusaka; Masafumi Ikeda; Chigusa Morizane; S Kondo; E Sugiyama; S R Kim; R Hasegawa; Y Saito; T Yoshida; N Saijo; J Sawada
Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.
British journal of cancer 2009;100(6):870-3.
2009: Kenji Hashimoto; Hideki Ueno; Masafumi Ikeda; Yasushi Kojima; Atsushi Hagihara; Shunsuke Kondo; Chigusa Morizane; Takuji Okusaka
Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?
Oncology 2009;77(3-4):217-23.
2009: Chigusa Morizane; Takuji Okusaka; Junji Furuse; Hiroshi Ishii; Hideki Ueno; Masafumi Ikeda; Kohei Nakachi; Mina Najima; Takashi Ogura; Eiichiro Suzuki
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2009;63(2):313-9.
2008: Tsutomu Tanaka; Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Atsushi Hagihara; Satoru Iwasa; Yasushi Kojima
Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.
Japanese journal of clinical oncology 2008;38(11):755-61.
2008: Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Yasushi Kojima; Satoru Iwasa; Atsushi Hagihara
Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
Japanese journal of clinical oncology 2008;38(10):675-82.
2008: Junji Furuse; Takuji Okusaka; Narikazu Boku; Shinichi Ohkawa; Akira Sawaki; Toshikazu Masumoto; Akihiro Funakoshi
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study.
Cancer chemotherapy and pharmacology 2008;62(5):849-55.
2008: Shumpei Ohnami; Yasunori Sato; Kimio Yoshimura; Sumiko Ohnami; Hiromi Sakamoto; Kazunori Aoki; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane; Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Ikuo Saito; Hiroshi Hirose; Daizo Saito; Haruhiko Sugimura; Tomoo Kosuge; Takuji Okusaka; Teruhiko Yoshida
His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
Gastroenterology 2008;135(2):477-88.
2008: Yoriko Takezako; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane; Mina Najima
Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
Hepato-gastroenterology 2008;55(85):1380-4.
2008: Takuji Okusaka; Yoshinori Ito; Junji Furuse; Shigeru Yamada; Hiroshi Ishii; Keiko Shibuya; Tatsuya Ioka; Hiroyuki Shinchi
Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan.
International journal of clinical oncology 2008;13(2):127-31.
2008: Tsutomu Tanaka; Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Takashi Ogura; Atsushi Hagihara; Satoru Iwasa
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Cancer chemotherapy and pharmacology 2008;61(4):683-8.
2008: Takuji Okusaka; Akihiro Funakoshi; Junji Furuse; Narikazu Boku; Kenji Yamao; Shinichi Ohkawa; Hiroshi Saito
A late phase II study of S-1 for metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2008;61(4):615-21.
2008: Su-Ryang Kim; Yoshiro Saito; Keiko Maekawa; Emiko Sugiyama; Nahoko Kaniwa; Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Chigusa Morizane; Noboru Yamamoto; Teruhiko Yoshida; Naoyuki Kamatani; Junji Furuse; Hiroshi Ishii; Nagahiro Saijo; Shogo Ozawa; Jun-Ichi Sawada
Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK).
Drug metabolism and pharmacokinetics 2008;23(5):379-84.
2008: Junichi Matsubara; Takuji Okusaka; Chigusa Morizane; Masafumi Ikeda; Hideki Ueno
Ultrasound-guided percutaneous pancreatic tumor biopsy in pancreatic cancer: a comparison with metastatic liver tumor biopsy, including sensitivity, specificity, and complications.
Journal of gastroenterology 2008;43(3):225-32.
2007: Kan Yonemori; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Yoriko Takesako; Masafumi Ikeda
FP therapy for controlling malignant ascites in advanced pancreatic cancer patients.
Hepato-gastroenterology 2007;54(80):2383-6.
2007: Naohiro Yonemoto; Junji Furuse; Takuji Okusaka; Kenji Yamao; Akihiro Funakoshi; Shinichi Ohkawa; Narikazu Boku; Katsuaki Tanaka; Michitaka Nagase; Hiromitsu Saisho; Tosiya Sato
A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer.
Japanese journal of clinical oncology 2007;37(11):843-51.
2007: Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge; Chigusa Morizane; Masafumi Ikeda; Hideki Ueno; Takuji Okusaka; Yasuaki Arai; Kenichi Takayasu
Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma.
Annals of surgical oncology 2007;14(8):2337-47.
2007: T Hamaguchi; K Kato; H Yasui; Chigusa Morizane; M Ikeda; H Ueno; K Muro; Y Yamada; Takuji Okusaka; K Shirao; Y Shimada; H Nakahama; Y Matsumura
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation.
British journal of cancer 2007;97(2):170-6.
2007: Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Chigusa Morizane; Takashi Ogura; Atsushi Hagihara; Tsutomu Tanaka
Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.
Japanese journal of clinical oncology 2007;37(7):515-20.
2007: Masafumi Ikeda; Takuji Okusaka; Yoshinori Ito; Hideki Ueno; Chigusa Morizane; Junji Furuse; Hiroshi Ishii; M Kawashima; Yoshikazu Kagami; Hiroshi Ikeda
A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
British journal of cancer 2007;96(11):1650-5.
2007: Hideki Ueno; Takuji Okusaka; Akihiro Funakoshi; Hiroshi Ishii; Kenji Yamao; Osamu Ishikawa; Shinichi Ohkawa; Soh Saitoh
A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2007;59(4):447-54.
2007: Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Satoru Iwasa; Atsushi Hagihara; Yasushi Kojima
Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Oncology 2007;72(3-4):188-93.
2007: Emiko Sugiyama; Nahoko Kaniwa; Su-Ryang Kim; Ruri Kikura-Hanajiri; Ryuichi Hasegawa; Keiko Maekawa; Yoshiro Saito; Shogo Ozawa; Jun-ichi Sawada; Naoyuki Kamatani; Junji Furuse; Hiroshi Ishii; Teruhiko Yoshida; Hideki Ueno; Takuji Okusaka; Nagahiro Saijo
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):32-42.
2006: Shunsuke Kondo; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane
Spontaneous regression of hepatocellular carcinoma.
International journal of clinical oncology 2006;11(5):407-11.
2006: Hideki Ueno; Tosiya Sato; Seiichiro Yamamoto; Katsuaki Tanaka; Shinichi Ohkawa; Hitoshi Takagi; Osamu Yokosuka; Junji Furuse; Hidetsugu Saito; Akira Sawaki; Hiroshi Kasugai; Yukio Osaki; Shigetoshi Fujiyama; Keiko Sato; Keiji Wakabayashi; Takuji Okusaka
Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C.
Cancer science 2006;97(10):1105-10.
2006: Yoshinori Ito; Takuji Okusaka; Yoshikazu Kagami; Hideki Ueno; Masafumi Ikeda; Minako Sumi; Atsushi Imai; Naoko Fujimoto; Hiroshi Ikeda
Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer.
Anticancer research 2006;26(5B):3755-9.
2006: Junji Furuse; Takuji Okusaka; Akihiro Funakoshi; Kenji Yamao; Michitaka Nagase; Hiroshi Ishii; Kohei Nakachi; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane; Yuki Horikawa; Nobumasa Mizuno
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Japanese journal of clinical oncology 2006;36(9):552-6.
2006: Takuji Okusaka; Hiroshi Ishii; Akihiro Funakoshi; Hideki Ueno; Junji Furuse; Toshihiko Sumii
A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer.
Japanese journal of clinical oncology 2006;36(9):557-63.
2006: Kenichi Takayasu; Yukio Muramatsu; Yasunori Mizuguchi; Takuji Okusaka; Kazuaki Shimada; Tadatoshi Takayama; Michiie Sakamoto
CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease.
AJR. American journal of roentgenology 2006;187(2):454-63.
2006: Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane
[S-1 monotherapy for pancreatic cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33 Suppl 1():207-12.
2006: Su-Ryang Kim; Yoshiro Saito; Keiko Maekawa; Emiko Sugiyama; Nahoko Kaniwa; Hideki Ueno; Takuji Okusaka; Chigusa Morizane; Noboru Yamamoto; Masafumi Ikeda; Teruhiko Yoshida; Hironobu Minami; Junji Furuse; Hiroshi Ishii; Nagahiro Saijo; Naoyuki Kamatani; Shogo Ozawa; Jun-ichi Sawada
Thirty novel genetic variations in the SLC29A1 gene encoding human equilibrative nucleoside transporter 1 (hENT1).
Drug metabolism and pharmacokinetics 2006;21(3):248-56.
2006: Takuji Okusaka; Hiroshi Ishii; Akihiro Funakoshi; Kenji Yamao; Shinichi Ohkawa; Soh Saito; Hiroshi Saito; Toshio Tsuyuguchi
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer.
Cancer chemotherapy and pharmacology 2006;57(5):647-53.
2006: Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane
[Non-surgical treatment for pancreatic cancer].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2006;103(4):391-7.
2006: Takuji Okusaka; Tesshi Yamada; Masato Maekawa
Serum tumor markers for pancreatic cancer: the dawn of new era?
JOP : Journal of the pancreas 2006;7(4):332-6.
2006: Kenichi Takayasu; Yukio Muramatsu; Yasunori Mizuguchi; Noriyuki Moriyama; Takuji Okusaka
Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Journal of gastroenterology and hepatology 2006;21(1 Pt 2):288-94.
2006: Masafumi Ikeda; Mina Najima; Chigusa Morizane; Hideki Ueno; Takuji Okusaka
[Palliative therapy in patients with biliary tract cancer].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 1():565-7.
2006: Chigusa Morizane; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda
[5 -fluoropyrimidines for treatment of biliary tract cancers].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 1():529-33.
2006: Mina Najima; Takuji Okusaka
[Tumor markers in biliary tract cancer].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 1():419-21.
2005: Junji Furuse; Hiroshi Ishii; Takuji Okusaka; Michitaka Nagase; Kohei Nakachi; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane; Masahiro Yoshino
Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer.
Japanese journal of clinical oncology 2005;35(12):733-8.
2005: Kazufumi Honda; Yasuharu Hayashida; Tomoko Umaki; Takuji Okusaka; Tomoo Kosuge; Satoru Kikuchi; Mitsufumi Endo; Akihiko Tsuchida; Tatsuya Aoki; Takao Itoi; Fuminori Moriyasu; Setsuo Hirohashi; Tesshi Yamada
Possible detection of pancreatic cancer by plasma protein profiling.
Cancer research 2005;65(22):10613-22.
2005: Toshimitsu Saisho; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Shuichi Okada
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Hepato-gastroenterology 2005;52(66):1654-8.
2005: Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Chigusa Morizane; Junji Furuse; Hiroshi Ishii
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Japanese journal of clinical oncology 2005;35(8):439-43.
2005: Kan Yonemori; Hideki Ueno; Takuji Okusaka; Noboru Yamamoto; Masafumi Ikeda; Nagahiro Saijo; Teruhiko Yoshida; Hiroshi Ishii; Junji Furuse; Emiko Sugiyama; Su-Ryang Kim; Ruri Kikura-Hanajiri; Ryuichi Hasegawa; Yoshiro Saito; Shogo Ozawa; Nahoko Kaniwa; Jun-ichi Sawada
Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2620-4.
2005: Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Yoriko Takezako; Chigusa Morizane
A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
Cancer 2005;103(4):756-62.
2005: Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Yoriko Ishiguro; Chigusa Morizane; Junichi Matsubara; Junji Furuse; Hiroshi Ishii; Michitaka Nagase; Kohei Nakachi
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer.
Oncology 2005;69(5):421-7.
2005: Chigusa Morizane; Takuji Okusaka; Yoshinori Ito; Hideki Ueno; Masafumi Ikeda; Yoriko Takezako; Yoshikazu Kagami; Hiroshi Ikeda
Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients.
Oncology 2005;68(4-6):432-7.
2005: Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Yoriko Takezako; Chigusa Morizane
An early phase II study of S-1 in patients with metastatic pancreatic cancer.
Oncology 2005;68(2-3):171-8.
2004: Takuji Okusaka; Hideki Ueno; Masafumi Ikeda
[Chemotherapy for hepatocellular carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(13):2122-8.
2004: Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Yoriko Takezako; Chigusa Morizane
Phase II study of S-1 in patients with advanced biliary tract cancer.
British journal of cancer 2004;91(10):1769-74.
2004: Yoriko Takezako; Takuji Okusaka; Hideki Ueno; Masahumi Ikeda; Chigusa Morizane; Mina Najima
[Tumor markers for pancreatic and biliary tract cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(9):1443-6.
2004: Takuji Okusaka; Yasuhiro Matsumura; Kazunori Aoki
New approaches for pancreatic cancer in Japan.
Cancer chemotherapy and pharmacology 2004;54 Suppl 1():S78-82.
2004: Takuji Okusaka; Yoshinori Ito; Hideki Ueno; Masafumi Ikeda; Yoriko Takezako; Chigusa Morizane; Yoshikazu Kagami; Hiroshi Ikeda
Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.
British journal of cancer 2004;91(4):673-7.
2004: Takuji Okusaka; Tomoo Kosuge
Systemic chemotherapy for pancreatic cancer.
Pancreas 2004;28(3):301-4.
2004: Takuji Okusaka; Shuichi Okada; Toshio Nakanishi; Shigetoshi Fujiyama; Yasuhiko Kubo
Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma.
Investigational new drugs 2004;22(2):169-76.
2004: Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Koich Tokuuye
Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
Oncology 2004;67(3-4):215-21.
2003: Koichi Tokuuye; Minako Sumi; Yoshikazu Kagami; Shigeyuki Murayama; Hiroshi Ikeda; Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Shuichi Okada
Small-field radiotherapy in combination with concomitant chemotherapy for locally advanced pancreatic carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(3):327-30.
2003: Chigusa Morizane; Shuichi Okada; Takuji Okusaka; Hideki Ueno; Toshimitsu Saisho
Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer.
Oncology 2003;64(4):475-6.
2002: Takuji Okusaka
Chemotherapy for biliary tract cancer in Japan.
Seminars in oncology 2002;29(6 Suppl 20):51-3.
2002: Masafumi Ikeda; Shuichi Okada; Seiichiro Yamamoto; Tosiya Sato; Hideki Ueno; Takuji Okusaka; Hitoshi Kuriyama; Kenichi Takayasu; Hiroyoshi Furukawa; Ryoko Iwata
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.
Japanese journal of clinical oncology 2002;32(11):455-60.
2002: Hitoshi Kuriyama; Shuichi Okada; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda
Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection.
Journal of gastroenterology and hepatology 2002;17(11):1205-10.
2002: Takuji Okusaka; Shuichi Okada; Hideki Ueno; Masafumi Ikeda; Kazuaki Shimada; Junji Yamamoto; Tomoo Kosuge; Susumu Yamasaki; Noriyoshi Fukushima; Michiie Sakamoto
Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.
Cancer 2002;95(9):1931-7.
2002: Shuichi Okada; Katsuaki Tanaka; Tosiya Sato; Hideki Ueno; Satoru Saito; Takuji Okusaka; Keiko Sato; Seiichiro Yamamoto; Tadao Kakizoe
Dose-response trial of lactoferrin in patients with chronic hepatitis C.
Japanese journal of cancer research : Gann 2002;93(9):1063-9.
2002: Masafumi Ikeda; Shuichi Okada; K Tokuuye; Hideki Ueno; Takuji Okusaka
A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
British journal of cancer 2002;86(10):1551-4.
2002: Hideki Ueno; Shuichi Okada; Takuji Okusaka; Masafumi Ikeda; Hitoshi Kuriyama
Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 2002;49(2):155-60.
2002: Takuji Okusaka; Shuichi Okada; Hideki Ueno; Masafumi Ikeda; Ryoko Iwata; Hiroyoshi Furukawa; Kenichi Takayasu; Noriyuki Moriyama; Tosiya Sato; Keiko Sato
Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma.
Oncology 2002;62(3):228-33.
2002: Hideki Ueno; Shuichi Okada; Takuji Okusaka; Masafumi Ikeda; Hitoshi Kuriyama
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Oncology 2002;62(3):223-7.
2001: Masafumi Ikeda; Shuichi Okada; Hideki Ueno; Takuji Okusaka; Hitoshi Kuriyama
Spontaneous regression of hepatocellular carcinoma with multiple lung metastases: a case report.
Japanese journal of clinical oncology 2001;31(9):454-8.
2001: H Ueno; Shuichi Okada; Takuji Okusaka; Masafumi Ikeda; N Tanaka; M Sakamoto; M Yoshimori
Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
Hepato-gastroenterology 2001;48(41):1430-4.
2001: Masafumi Ikeda; Shuichi Okada; Hideki Ueno; Takuji Okusaka; Hitoshi Kuriyama
Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study.
Japanese journal of clinical oncology 2001;31(7):322-6.
2001: Takuji Okusaka; Shuichi Okada; H Ueno; Masafumi Ikeda; K Shimada; J Yamamoto; T Kosuge; S Yamasaki; N Fukushima; M Sakamoto
Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings.
Pancreas 2001;22(3):279-84.
2001: Takuji Okusaka; Shuichi Okada; K Tokuuye; H Wakasugi; H Saisho; O Ishikawa; S Matsuno; T Sato; K Sato
Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.
Cancer 2001;91(7):1384-9.
2001: Kenichi Takayasu; Y Muramatsu; T Maeda; Ryoko Iwata; H Furukawa; Yukio Muramatsu; Noriyuki Moriyama; Takuji Okusaka; S Okada; H Ueno
Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.
AJR. American journal of roentgenology 2001;176(3):681-8.
2001: Masafumi Ikeda; Shuichi Okada; K Tokuuye; Hideki Ueno; Takuji Okusaka
Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.
Cancer 2001;91(3):490-5.
2001: Shuichi Okada; Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; Junji Furuse; Yasushi Maru
Phase I trial of gemcitabine in patients with advanced pancreatic cancer.
Japanese journal of clinical oncology 2001;31(1):7-12.
2000: M Fujishiro; Shuichi Okada; Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; H Watanabe; N Tanaka
Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer.
Hepato-gastroenterology 2000;47(36):1744-6.
2000: Hideki Ueno; Shuichi Okada; Takuji Okusaka; Masafumi Ikeda
Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy.
Oncology 2000;59(4):296-301.
2000: Koichi Tokuuye; M Sumi; Y Kagami; S Murayama; M Kawashima; H Ikeda; H Ueno; Takuji Okusaka; S Okada
Radiotherapy for hepatocellular carcinoma.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(9):406-10.
2000: Masafumi Ikeda; Shuichi Okada; H Ueno; Takuji Okusaka; N Tanaka; H Kuriyama; M Yoshimori
A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.
Hepato-gastroenterology 2000;47(33):862-5.
2000: Takuji Okusaka; Shuichi Okada; H Ueno; Masafumi Ikeda; M Yoshimori; K Shimada; J Yamamoto; T Kosuge; S Yamasaki; Ryoko Iwata; H Furukawa; Noriyuki Moriyama; M Sakamoto; S Hirohashi
Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma.
Oncology 2000;58(4):293-9.
2000: N Tanaka; Shuichi Okada; H Ueno; Takuji Okusaka; Masafumi Ikeda
The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer.
Pancreas 2000;20(4):378-81.
1999: H Nose; Shuichi Okada; Takuji Okusaka; Junji Furuse; Masahiro Yoshino; K Ogoshi; T Kato; M Miyaji; M Hoshino; Joe Ariyama; M Suyama; E Karasawa; M Yoshimori
5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
Hepato-gastroenterology 1999;46(30):3244-8.
1999: H Nagahama; Shuichi Okada; Takuji Okusaka; H Ishii; Masafumi Ikeda; H Nakasuka; M Yoshimori
Clinicopathological features in misdiagnosed pancreatic carcinoma.
Hepato-gastroenterology 1999;46(29):2983-5.
1999: H Kosakamoto; Shuichi Okada; Hideki Ueno; Takuji Okusaka; Masafumi Ikeda; N Tanaka; M Yoshimori; Y Matsuno
A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
Hepato-gastroenterology 1999;46(28):2621-4.
1998: Takuji Okusaka; Shuichi Okada; H Ishii; Masafumi Ikeda; H Nakasuka; H Nagahama; Ryoko Iwata; H Furukawa; Kenichi Takayasu; Y Nakanishi; M Sakamoto; S Hirohashi; M Yoshimori
Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
Oncology 1998;55(4):276-83.
1998: H Nakasuka; Shuichi Okada; Takuji Okusaka; H Ishii; Masafumi Ikeda; R Ito; H Kosakamoto; M Yoshimori; Y Nakanishi; M Sakamoto
Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.
Japanese journal of clinical oncology 1998;28(6):401-4.
1998: Shuichi Okada; T Sato; Takuji Okusaka; H Ishii; Masafumi Ikeda; H Nakasuka; H Kosakamoto; M Yoshimori; K Wakabayashi
Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.
British journal of cancer 1998;77(11):2028-31.
1998: Takuji Okusaka; Shuichi Okada; T Sato; H Wakasugi; H Saisho; Junji Furuse; O Ishikawa; S Matsuno; S Yokoyama
Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer.
Hepato-gastroenterology 1998;45(21):867-72.
1998: H Ishii; Shuichi Okada; Takuji Okusaka; M Yoshimori; H Nakasuka; K Shimada; S Yamasaki; Y Nakanishi; M Sakamoto
Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection.
Cancer 1998;82(9):1638-42.
1998: Takuji Okusaka; Shuichi Okada; H Ishii; Masafumi Ikeda; H Kosakamoto; M Yoshimori
Prognosis of advanced pancreatic cancer patients with reference to calorie intake.
Nutrition and cancer 1998;32(1):55-8.
1998: Shuichi Okada; Takuji Okusaka; H Ishii; A Kyogoku; M Yoshimori; N Kajimura; K Yamaguchi; T Kakizoe
Elevated serum interleukin-6 levels in patients with pancreatic cancer.
Japanese journal of clinical oncology 1998;28(1):12-5.
1997: Takuji Okusaka; Shuichi Okada; H Ishii; H Nagahama; M Yoshimori; S Yamasaki; Kenichi Takayasu; T Kakizoe; A Ochiai; T Shimoda
Hepatocellular carcinoma with gastrointestinal hemorrhage caused by direct tumor invasion to the duodenum.
Japanese journal of clinical oncology 1997;27(5):343-5.
1997: H Nagahama; Shuichi Okada; Takuji Okusaka; H Ishii; Masafumi Ikeda; H Nakasuka; M Yoshimori
Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.
Japanese journal of clinical oncology 1997;27(5):321-4.
1997: H Ishii; Shuichi Okada; K Tokuuye; H Nose; Takuji Okusaka; M Yoshimori; H Nagahama; M Sumi; Y Kagami; Hiroshi Ikeda
Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
Cancer 1997;79(8):1516-20.
1997: Shuichi Okada; H Ishii; H Nose; Takuji Okusaka; A Kyogoku; M Yoshimori; K Wakabayashi
Evidence for increased somatic cell mutations in patients with hepatocellular carcinoma.
Carcinogenesis 1997;18(2):445-9.
1997: Takuji Okusaka; K Eguchi; T Kasai; T Kurata; N Yamamoto; Yuichiro Ohe; T Tamura; T Shinkai; Nagahiro Saijo
Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):123-7.
1997: Takuji Okusaka; Shuichi Okada; H Ishii; H Nose; H Nagahama; H Nakasuka; Kenji Ikeda; M Yoshimori
Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.
Hepato-gastroenterology 1997;44(13):251-7.
1996: Shuichi Okada; H Ishii; H Nose; Takuji Okusaka; A Kyogoku; M Yoshimori; K Shimada; J Yamamoto; T Kosuge; S Yamasaki; M Sakamoto; S Hirohashi
Effect of heavy alcohol intake on long-term results after curative resection of hepatitis C virus-related hepatocellular carcinoma.
Japanese journal of cancer research : Gann 1996;87(8):867-73.
1996: Takuji Okusaka; Shuichi Okada; H Ishii; H Nose; H Nakasuka; H Nakayama; H Nagahama
Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.
Japanese journal of clinical oncology 1996;26(4):215-20.
1996: H Ishii; Shuichi Okada; H Nose; Takuji Okusaka; H Nagahama; H Nakayama; H Nakasuka; M Yoshimori
Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Hepato-gastroenterology 1996;43(10):938-43.
1996: Takuji Okusaka; Shuichi Okada; H Nose; H Ishii; H Nakasuka; H Nakayama; H Nagahama; M Yoshimori; K Shimada; J Yamamoto; T Takayama; T Kosuge; S Yamasaki; M Sakamoto; S Hirohashi
The prognosis of patients with hepatocellular carcinoma of multicentric origin.
Hepato-gastroenterology 1996;43(10):919-25.
1996: H Ishii; S Okada; T Sato; H Nose; Takuji Okusaka; M Yoshimori; K Takayasu; T Takayama; T Kosuge; S Yamasaki
Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
Hepato-gastroenterology 1996;43(9):644-50.
1996: H Ishii; Shuichi Okada; H Nose; Takuji Okusaka; M Yoshimori; T Takayama; T Kosuge; S Yamasaki; M Sakamoto; S Hirohashi
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
Cancer 1996;77(9):1792-6.
1996: H Ishii; S Okada; H Nose; M Yoshimori; K Aoki; Takuji Okusaka
Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy.
Pancreas 1996;12(3):267-71.
1995: Shuichi Okada; H Ishii; H Nose; Takuji Okusaka; A Kyogoku; M Yoshimori; M Sakamoto; S Hirohashi
Intratumoral DNA heterogeneity of small hepatocellular carcinoma.
Cancer 1995;75(2):444-50.
1994: Shuichi Okada; H Ishii; H Nose; M Yoshimori; Takuji Okusaka; K Aoki; M Iwasaki; Junji Furuse; Masahiro Yoshino
A phase II study of cisplatin in patients with biliary tract carcinoma.
Oncology 1994;51(6):515-7.